-
The growth of biotech industry is being driven by two major factors – (VVUS, ARNA, SQNM, DNDN)
The Biotech Industry has rallied this year as the higher number of new drug approvals has raised investor confidence within the industry. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) and SPDR S&P Biotech (ETF) (NYSEARCA:XBI) have both risen over 25 percent so far in 2012. There was another key factor behind the Biotech Industry’s success…
-
Florida becomes the Most Rapidly Growing State in Adding New Biotech Companies – (NPSP, ARNA, AEZS, VVUS)
A global report by research firm Battelle, the world’s largest private contract research and development organization, claims that Florida is the most rapidly growing state in creating new biotech companies and ranks second in medical device firms. According to a University of Florida life science database, the southeastern region of the state including Broward and…
-
Key Biotech Event Today – (QCOR, CTIC, ARNA, VVUS)
Governor John Kitzhaber recently declared Tuesday, Oct. 9, 2012, as “Oregon Digital Health and Bioscience Day,” opening Oregon’s biggest bioscience conference ever, with symposia, networking, poster sessions, and thought-leadership debate on the local and growth of the bioscience industry across the globe. The two-day Oregon Bio 2012 at Marylhurst University was predicted to attract up…
-
As Worst U.S. Drought Withers Corn, Biotech Firms Expect Fruitful Opportunity – (ARNA, QCOR, AEZS, VVUS)
The most horrible U.S. drought in half a century is weakening the country’s corn crop, but it’s a fruitful opportunity for developers of genetically modified crops. Agricultural biotechnology companies have been spending big amount of dollars into developing plants that can resist the impacts of an extended dry spell. Monsanto Co., based in St. Louis,…
-
Biotechnology IPOs Have an Edge Over The Internet Giants – (FB, GRPN, ARNA, GILD, VVUS, CELG)
Companies in the biotech industry are not exactly household names such as Facebook Inc (NASDAQ:FB) or Groupon Inc (NASDAQ:GRPN), but they can possess one advantage over the Internet giants i.e. better stock performance after their initial public offering. The greater part of the nine U.S. biotech companies that have gone public in 2012 are currently…
-
Study Finds Less Life Expectancy Among Poor And Less-Educated U.S. Citizens – (ARNA, VVUS, ZLCS)
For poor and less-educated U.S. citizens, life expectancy has grown only slightly over the last several decades despite the latest medical advances, researchers say. The new study reveals life expectancy for people who do not complete high school is actually getting shorter in some cases. On the other side, highly educated Americans with more socioeconomic…
-
List Of Key Pending FDA Drug Approval Decisions Between July and February 2013– (ARNA, STEM, VVUS)
An updated list of biotech and pharmaceutical companies that have pending FDA drug approval decisions for the remainder of the year and into early 2013 has been released. The calendar provides you the most important U.S. regulatory events including FDA drug approvals and advisory panels scheduled between July and February 2013. As all savvy biotech…
-
The U.S. Weight Loss Market Expected to be Worth More Than $60 Billion Annually – (PFE, VVUS, ARNA)
The U.S. Food and Drug Administration, after a 13-year dry spell, recently provided an approval for two new drugs including Belviq and Qsymia. The question will be about how to get a prescription for them. The answer may perhaps depend on which doctor you select to see. Greg Anderson, an assistant professor of family medicine…